The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis

Peer Review reports

Original Submission
20 Jun 2021	Submitted	Original manuscript
14 Jul 2021	Reviewed	Reviewer Report
21 Jul 2021	Reviewed	Reviewer Report
28 Jul 2021	Reviewed	Reviewer Report
4 Aug 2021	Reviewed	Reviewer Report
20 Aug 2021	Author responded	Author comments - Yao-dong Zhu
4 Oct 2021	Reviewed	Reviewer Report
6 Oct 2021	Reviewed	Reviewer Report - federica giugliano
Resubmission - Version 2
20 Aug 2021	Submitted	Manuscript version 2
Publishing
21 Oct 2021	Editorially accepted
13 Nov 2021	Article published	10.1186/s12885-021-08924-z

Back to article page